Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01220739 · ClinicalTrials.gov registry record · Phase 2
Safety of Rt-PA + Transcranial Emission of Low-Energy Lasers for Acute Stroke Recovery
A Phase 2 study, sponsored by University of California, San Diego.
- Terminated
- Registry status
- Phase 2
- Development phase
- 12
- Enrollment target
NCT01220739 is a Phase 2 study that was terminated before completion, run by University of California, San Diego. The registered enrollment target is 12 participants.
The verdict
NCT01220739, a Phase 2 study, was terminated before completion, sponsored by University of California, San Diego.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 12 participants
- Enrollment target
Study Summary
To assess the safety and preliminary efficacy of combining intravenous rt-PA with transcranial laser therapy (TLT) with the NeuroThera® Laser System (referred to hereafter as NTS) in subjects treated for acute ischemic stroke. Treatment with IV rt-PA must begin within 3 hours of symptom onset, and the initiation of TLT procedure must be feasible for each subject within 6 hours of stroke onset. The NeuroThera® Laser System is an investigational device that provides noninvasive transcranial laser therapy to subjects diagnosed with acute ischemic stroke. The wavelength of the laser light is in the infrared zone of the electromagnetic spectrum and is invisible to the naked eye.
Interventions
- DEVICE Transcranial Laser Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2011-06 |
| Est. Completion | 2013-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01220739
The ClinicalTrials.gov registry entry for NCT01220739 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transcranial Laser Therapy is the first listed.
NCT01220739 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01220739 about?
NCT01220739 is a clinical study titled "Safety of Rt-PA + Transcranial Emission of Low-Energy Lasers for Acute Stroke Recovery". To assess the safety and preliminary efficacy of combining intravenous rt-PA with transcranial laser therapy (TLT) with the NeuroThera® Laser System (referred to hereafter as NTS) in subjects treated for acute ischemic stroke. Treatment with IV rt-PA must begin within 3 hours of symptom onset, and t...
What is the current status of trial NCT01220739?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 2011-06. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01220739?
The interventions under investigation include: Transcranial Laser Therapy (DEVICE).
Who is sponsoring clinical trial NCT01220739?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.